儿童膀胱输尿管反流再植术后30天UTI率及出院抗生素作用分析
基于NSQIP-VUR数据库的回顾性队列研究纳入3004例因膀胱输尿管反流行输尿管再植术的患儿,比较出院带抗生素与不带抗生素者的30天UTI率、再入院和急诊就诊。单因素分析显示两组无差异,多因素分析中年龄和女性是UTI独立预测因素,出院抗生素处方未显著影响UTI率。
要点
- 出院带抗生素与不带抗生素的30天UTI率无显著差异。
- 年龄较小和女性是术后30天UTI的独立预测因素。
- 常规出院预防性抗生素可能不降低早期UTI风险。
核心结论
- 年龄和性别可预测VUR再植术后30天内UTI风险。
- 出院时预防性抗生素处方未显著降低早期UTI风险,常规处方可能不必要。
研究设计与样本
- 回顾性队列研究,利用儿科NSQIP VUR特异性数据集。
- 纳入3004例因VUR行输尿管再植术的患儿。
主要发现
- 出院带抗生素组2509例(84%),不带抗生素组495例(16%)。
- 30天再入院率3.9% vs 5.3%、急诊就诊率10.5% vs 10.5%、UTI率2.4% vs 3.2%,均无统计学差异(P>.05)。
- 多因素分析:年龄OR 0.986(95%CI 0.978-0.994),女性OR 1.782(95%CI 1.005-3.162)为UTI显著预测因素。
- 出院抗生素处方OR 1.564(95%CI 0.886-2.763),对UTI率无显著影响。
关键数值与推荐
- 年龄每增加1岁,UTI风险略降低(OR 0.986,95%CI 0.978-0.994)。
- 女性UTI风险约为男性1.782倍(95%CI 1.005-3.162)。
- 出院抗生素处方OR 1.564(95%CI 0.886-2.763),无统计学意义。
临床怎么用
- 术后可依据年龄和性别评估UTI风险,而非常规开具出院抗生素。
- 抗生素管理应避免不必要的出院预防性用药。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 原文未报告反流级别、围手术期支架使用等亚组的具体数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate 30-day postoperative urinary tract infection (UTI) rates in children with vesicoureteral reflux (VUR) undergoing ureteral reimplantation, assessing the impact of discharge antibiotics. METHODS: This retrospective cohort study utilized the pediatric National Surgical Quality Improvement Program VUR-specific dataset to analyze patients who underwent ureteral reimplantation for VUR. We compared 30-day UTI rates, readmissions, and ER visits between those discharged with and without antibiotics. Multivariable logistic regression identified independent predictors of UTIs. RESULTS: Of the 3004 patients included who underwent ureteral reimplant, 2509 (84%) and 495 (16%) were discharged with or without antibiotics, respectively. On univariable analysis, the proportion of patients who experienced 30-day readmission (3.9% vs 5.3%), emergency room visits (10.5% vs 10.5%), and UTI (2.4% vs 3.2%) did not differ according to discharge antibiotic use (antibiotics vs no antibiotics, respectively, all P>.05). On MVA, age (Odds Ratio [OR]: 0.986, 95% CI: 0.978-0.994) and female sex (OR: 1.782, 95% CI: 1.005-3.162) were found to be significant predictors of UTI occurrence. Conversely, the prescription of antibiotics at discharge (OR: 1.564, 95% CI: 0.886-2.763) did not show a significant impact on UTI rates. CONCLUSION: Age and sex are predictive of UTI risk within 30 days following ureteral reimplantation for VUR. The absence of significant associations for reflux grade, perioperative stent use, or prophylactic antibiotic administration at discharge suggests that routine prescription of antibiotics post-discharge may not reduce early UTI risk. These findings can guide postoperative care and help tailor antibiotic stewardship efforts in pediatric urology.
引用
- Pfail J, Passarelli R, Concodora C, et al. Contemporary Analysis of 30-Day UTI Rates Post-ureteral Reimplantation in VUR Patients: Evaluating the Role of Discharge Antibiotics. Urology. 2025. PMID: 41371507. doi:10.1016/j.urology.2025.11.249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。